2017
DOI: 10.1074/jbc.m117.789883
|View full text |Cite
|
Sign up to set email alerts
|

A dock and coalesce mechanism driven by hydrophobic interactions governs Cdc42 binding with its effector protein ACK

Abstract: Cdc42 is a Rho-family small G protein that has been widely studied for its role in controlling the actin cytoskeleton and plays a part in several potentially oncogenic signaling networks. Similar to most other small G proteins, Cdc42 binds to many downstream effector proteins to elicit its cellular effects. These effector proteins all engage the same face of Cdc42, the conformation of which is governed by the activation state of the G protein. Previously, the importance of individual residues in conferring bin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
30
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 14 publications
(33 citation statements)
references
References 39 publications
(80 reference statements)
3
30
0
Order By: Relevance
“…This is consistent with the previous observation that P7 can compete with ACK GBD binding to Cdc42 ( Figure 1C), which implies overlapping binding sites. Importantly this region of Cdc42 contributes significantly thermodynamically to the binding of both ACK and WASP (18,37) and is also demonstrated to bind the other known CRIB effectors PAK1 and Par6 where structural information is available ( Figure 6), suggesting that P7 will disrupt binding to these proteins as well.…”
Section: Inhibition Of Ras-cdc42 Signalling By a Cyclic Peptidementioning
confidence: 99%
See 2 more Smart Citations
“…This is consistent with the previous observation that P7 can compete with ACK GBD binding to Cdc42 ( Figure 1C), which implies overlapping binding sites. Importantly this region of Cdc42 contributes significantly thermodynamically to the binding of both ACK and WASP (18,37) and is also demonstrated to bind the other known CRIB effectors PAK1 and Par6 where structural information is available ( Figure 6), suggesting that P7 will disrupt binding to these proteins as well.…”
Section: Inhibition Of Ras-cdc42 Signalling By a Cyclic Peptidementioning
confidence: 99%
“…This inhibits Cdc42-driven signalling pathways, which must be necessary for transformation by Ras in this model. This observation, together with our structural and biophysical analysis of the Cdc42-ACK GBD complex (17,18) prompted us to undertake a peptide discovery campaign, using CIS display technology, to identify a Cdc42 binding peptide that would similarly inhibit effector interaction and Ras-driven oncogenesis but would possess properties more compatible with future use as a lead therapeutic. CIS display is a biological display technology that links the DNA coding sequence of library members directly to the encoded peptide in a cell-free system by employing the binding properties of the R1 RepA protein to the origin of replication i.e.…”
Section: Inhibition Of Ras-cdc42 Signalling By a Cyclic Peptidementioning
confidence: 99%
See 1 more Smart Citation
“…The k on and k off rates for Cdc42-WASP are 0.793 µM -1 s -1 and 19.9 ms -1 respectively. The k on and k off rates for Cdc42-ACK are 0.224 µM -1 s -1 and 27.8 ms -1 respectively as measured by biolayer interferometry (18). Waals surface of the Cdc42-ACK structure (pdb entry 1CF4).…”
Section: Discussionmentioning
confidence: 99%
“…This hydrophobic patch interaction is further extended by Ile454 ACK (see below), which contacts Leu177, Ile46, Gly47 and Gly48 Cdc42, all of which are structurally stable. An intense concentration of hydrophobic potential is found on Cdc42, complementing the N-terminal hydrophobic residues of ACK and giving it plausible docking potential (18). This hydrophobic potential is also apparent in free Cdc42 in the GTP-bound form and so would be accessible to form an encounter complex ( Figure 5).…”
Section: As Seen Inmentioning
confidence: 98%